These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37971760)

  • 1. Sphingolipids and HSC fitness: enigma no more.
    Xie SZ
    Blood; 2023 Nov; 142(20):1674-1676. PubMed ID: 37971760
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
    Adada M; Luberto C; Canals D
    Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral sphingomyelinase blockade enhances hematopoietic stem cell fitness through an integrated stress response.
    Hurwitz SN; Jung SK; Kobulsky DR; Fazelinia H; Spruce LA; Pérez EB; Groen N; Mesaros C; Kurre P
    Blood; 2023 Nov; 142(20):1708-1723. PubMed ID: 37699202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sphingolipids in the process of signal transduction.
    Riboni L; Viani P; Bassi R; Prinetti A; Tettamanti G
    Prog Lipid Res; 1997 Sep; 36(2-3):153-95. PubMed ID: 9624426
    [No Abstract]   [Full Text] [Related]  

  • 5. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
    Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
    J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids and cell function.
    Ballou LR
    Immunol Today; 1992 Sep; 13(9):339-41. PubMed ID: 1466749
    [No Abstract]   [Full Text] [Related]  

  • 7. SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B.
    Fan W; Tang S; Fan X; Fang Y; Xu X; Li L; Xu J; Li JL; Wang Z; Li X
    Elife; 2021 May; 10():. PubMed ID: 34042046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The potential role for sphingolipids in neuropathogenesis of Alzheimer's disease].
    Alesenko AV
    Biomed Khim; 2013; 59(1):25-50. PubMed ID: 23650721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids in inflammatory hypoxia.
    Glaser UG; Fandrey J
    Biol Chem; 2018 Sep; 399(10):1169-1174. PubMed ID: 29908122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer: Killing from the inside.
    Saftig P; Sandhoff K
    Nature; 2013 Oct; 502(7471):312-3. PubMed ID: 24089207
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
    Yu Z; Peng Q; Huang Y
    Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated sphingolipid metabolism in endometriosis.
    Lee YH; Tan CW; Venkatratnam A; Tan CS; Cui L; Loh SF; Griffith L; Tannenbaum SR; Chan JK
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1913-21. PubMed ID: 24960545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transcriptional regulation of sphingolipid metabolic enzymes].
    Murate T
    Seikagaku; 2007 Dec; 79(12):1139-43. PubMed ID: 18203454
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood sphingolipids in homeostasis and pathobiology.
    Hammad SM
    Adv Exp Med Biol; 2011; 721():57-66. PubMed ID: 21910082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids in thyroid eye disease.
    Gulbins A; Görtz GE; Gulbins E; Eckstein A
    Front Endocrinol (Lausanne); 2023; 14():1170884. PubMed ID: 37082124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays for transmembrane movement of sphingolipids.
    Sillence DJ; Raggers RJ; van Meer G
    Methods Enzymol; 2000; 312():562-79. PubMed ID: 11070902
    [No Abstract]   [Full Text] [Related]  

  • 17. Sphingolipids: important players in multiple sclerosis.
    Halmer R; Walter S; Faßbender K
    Cell Physiol Biochem; 2014; 34(1):111-8. PubMed ID: 24977485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and regulation of bioactive sphingolipids.
    Heffernan-Stroud LA; Obeid LM
    Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
    Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
    Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
    Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
    J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.